{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T22:26:23Z","timestamp":1749853583814},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,4,28]],"date-time":"2018-04-28T00:00:00Z","timestamp":1524873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s11938-018-0183-1","type":"journal-article","created":{"date-parts":[[2018,4,28]],"date-time":"2018-04-28T01:57:09Z","timestamp":1524880629000},"page":"253-259","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Management of Hepatic Encephalopathy Not Responsive to First-Line Treatments"],"prefix":"10.1007","volume":"16","author":[{"given":"Silvia","family":"Nardelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Ridola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Gioia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliviero","family":"Riggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,28]]},"reference":[{"key":"183_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/hep.26370","volume":"58","author":"P Amodio","year":"2013","unstructured":"Amodio P, Bemeur C, Butterworth R, Cordoba J, Kato A, Montagnese S, et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology. 2013;58:325\u201336.","journal-title":"Hepatology"},{"issue":"2","key":"183_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"\u2022\u2022 Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60(2):715\u201335. These International practice guidelines could be very useful for practitioners in the management of patients with HE","journal-title":"Hepatology."},{"issue":"3","key":"183_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/cld.457","volume":"5","author":"O Riggio","year":"2015","unstructured":"\u2022 Riggio O, Nardelli S, Gioia S, Lucidi C, Merli M. Management of hepatic encephalopathy as an inpatient. Clinical Liver Disease. 2015;5(3):79\u201382. This paper could be useful to guide physicians in differential diagnosis of HE","journal-title":"Clinical Liver Disease"},{"issue":"11","key":"183_CR4","first-page":"659","volume":"13","author":"G Pantham","year":"2017","unstructured":"Pantham G, Mullen KD. Practical issues in the management of overt hepatic encephalopathy. Gastroenterol Hepatol (N Y). 2017;13(11):659\u201365.","journal-title":"Gastroenterol Hepatol (N Y)."},{"key":"183_CR5","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.jhep.2013.07.020","volume":"59","author":"M Sim\u00f3n-Talero","year":"2013","unstructured":"Sim\u00f3n-Talero M, Garc\u00eda-Mart\u00ednez R, Torrens M, et al. Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study. J Hepatol. 2013;59:1184\u201392.","journal-title":"J Hepatol."},{"key":"183_CR6","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/jgh.13666","volume":"32","author":"BC Sharma","year":"2017","unstructured":"Sharma BC, Singh J, Srivastava S, et al. Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy. J Gastroenterol Hepatol. 2017;32:1234\u20139.","journal-title":"J Gastroenterol Hepatol."},{"key":"183_CR7","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/ajg.2013.219","volume":"108","author":"BC Sharma","year":"2013","unstructured":"Sharma BC, Sharma P, Lunia MK, et al. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol. 2013;108:1458\u201363.","journal-title":"Am J Gastroenterol."},{"key":"183_CR8","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1001\/jamainternmed.2014.4746","volume":"174","author":"RS Rahimi","year":"2014","unstructured":"Rahimi RS, Singal AG, Cuthbert JA, et al. Lactulose vs polyethylene glycol 3350-electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial. JAMA Intern Med. 2014;174:1727\u201333.","journal-title":"JAMA Intern Med."},{"key":"183_CR9","doi-asserted-by":"publisher","unstructured":"Sidhu SS, Sharma BC, Goyal O, et al. L-ornithine L-aspartate in bouts of overt hepatic encephalopathy. Hepatology. 2017. Jul 27; \n                      https:\/\/doi.org\/10.1002\/hep.29410\n                      \n                    .","DOI":"10.1002\/hep.29410"},{"key":"183_CR10","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/hep.29306","volume":"66","author":"JS Bajaj","year":"2017","unstructured":"\u2022\u2022 Bajaj JS, Kassam Z, Fagan A, et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial. Hepatology. 2017;66:1727\u201338. This study is very interesting because it demonstrated for the first time the efficacy of fecal microbiota transplant in the treatment of HE","journal-title":"Hepatology"},{"issue":"10","key":"183_CR11","doi-asserted-by":"publisher","first-page":"e0140450","DOI":"10.1371\/journal.pone.0140450","volume":"10","author":"L Schmidt","year":"2015","unstructured":"Schmidt L, G\u00f8rtz S, Wohlfahrt J, Melbye M, Munch TN. Recurrence of subdural haematoma in a population-based cohort\u2014risks and predictive factors. PLoS One. 2015;10(10):e0140450.","journal-title":"PLoS One."},{"issue":"1","key":"183_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cgh.2014.05.022","volume":"13","author":"LM Donovan","year":"2015","unstructured":"Donovan LM, Kress WL, Strnad LC, et al. Low likelihood of intracranial hemorrhage in patients with cirrhosis and altered mental status. Clin Gastroenterol Hepatol. 2015;13(1):165\u20139.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"183_CR13","doi-asserted-by":"crossref","unstructured":"Sharma BC, Sharma P, Agrawal A, Sarin SK. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology. 2009;137(3):885\u201391. 891","DOI":"10.1053\/j.gastro.2009.05.056"},{"issue":"12","key":"183_CR14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","volume":"362","author":"NM Bass","year":"2010","unstructured":"Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362(12):1071\u201381.","journal-title":"N Engl J Med."},{"issue":"5","key":"183_CR15","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/hep.20905","volume":"42","author":"O Riggio","year":"2005","unstructured":"\u2022 Riggio O, Efrati C, Catalano C, Pediconi F, Mecarelli O, Accornero N, et al. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study. Hepatology. 2005;42(5):1158\u201365. This study demonstrated that in patients with recurrent HE, there is a high prevalence of large porto systemic shunts that need to be searched by a CT scan","journal-title":"Hepatology."},{"key":"183_CR16","first-page":"450","volume":"81","author":"K Ohnishi","year":"1986","unstructured":"Ohnishi K, Sato S, Saito M, Terabayashi H, Nakayama T, Saito M, et al. Clinical and hemodynamic features in cirrhotic patients having a large spontaneous splenorenal and\/or gastrorenal shunt. Am J Gastroenterol. 1986;81:450\u20135.","journal-title":"Am J Gastroenterol"},{"key":"183_CR17","unstructured":"Sim\u00f3n-Talero M, Roccarina D, Mart\u00ednez J, Lampichler K, Baiges A, Low G, et al. Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis. Gastroenterology. 2018 Jan 20. pii: S0016-5085(18)30069-6."},{"issue":"5","key":"183_CR18","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jhep.2013.06.014","volume":"59","author":"M R\u00f6ssle","year":"2013","unstructured":"R\u00f6ssle M. TIPS: 25 years later. J Hepatol. 2013;59(5):1081\u201393. \n                      https:\/\/doi.org\/10.1016\/j.jhep.2013.06.014\n                      \n                    . Review","journal-title":"J Hepatol."},{"key":"183_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1053\/j.gastro.2003.11.016","volume":"126","author":"C Bureau","year":"2004","unstructured":"Bureau C, Garcia-Pagan JC, Otal P, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology. 2004;126:469\u201375.","journal-title":"Gastroenterology"},{"issue":"1","key":"183_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cld.2011.12.008","volume":"16","author":"O Riggio","year":"2012","unstructured":"Riggio O, Nardelli S, Moscucci F, Pasquale C, Ridola L, Merli M. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Clin Liver Dis. 2012 Feb;16(1):133\u201346.","journal-title":"Clin Liver Dis."},{"key":"183_CR21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/gut.2005.089482","volume":"55","author":"N Kochar","year":"2006","unstructured":"Kochar N, Tripathi D, Ireland H, et al. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy. Gut. 2006;55:617\u201323.","journal-title":"Gut"},{"key":"183_CR22","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1111\/j.1572-0241.2008.02102.x","volume":"103","author":"O Riggio","year":"2008","unstructured":"Riggio O, Angeloni S, Salvatori FM, et al. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol. 2008;103:2738\u201346.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"183_CR23","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1002\/hep.26314","volume":"57","author":"W Laleman","year":"2013","unstructured":"Laleman W, Simon-Talero M, Maleux G, Perez M, Ameloot K, Soriano G, et al. EASL-CLIF-Consortium. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology. 2013;57(6):2448\u201357.","journal-title":"Hepatology."},{"issue":"12","key":"183_CR24","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1111\/apt.12771","volume":"39","author":"J An","year":"2014","unstructured":"An J, Kim KW, Han S, et al. Improvment in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy. Aliment Pharmacol Ther. 2014;39(12):1418\u201326.","journal-title":"Aliment Pharmacol Ther."},{"key":"183_CR25","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.jvir.2015.07.011","volume":"26","author":"D Gwon","year":"2015","unstructured":"Gwon D, Kim Y, Ko G, Kim J, Ko H, Kim J, et al. Vascular plug-assisted retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy: a prospective multicenter study. J Vasc Interv Radiol. 2015;26:1589\u201395.","journal-title":"J Vasc Interv Radiol"},{"issue":"7","key":"183_CR26","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s00270-017-1593-5","volume":"40","author":"A Mukund","year":"2017","unstructured":"Mukund A, Deogaonkar G, Rajesh S, et al. Safety and Efficacy of Sodium Tetradecyl Sulfate and Lipiodol Foam in Balloon-OccludedRetrograde Transvenous Obliteration (BRTO) for Large Porto-Systemic Shunts. Cardiovasc Intervent Radiol. 2017;40(7):1010\u20136.","journal-title":"Cardiovasc Intervent Radiol."},{"issue":"1","key":"183_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","volume":"152","author":"C Bureau","year":"2017","unstructured":"Bureau C, Thabut D, Oberti F, et al. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites. Gastroenterology. 2017 Jan;152(1):157\u201363.","journal-title":"Gastroenterology."},{"key":"183_CR28","doi-asserted-by":"crossref","unstructured":"De Santis A, Nardelli S, Bassanelli C, et al. The modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol. 2017.","DOI":"10.1111\/jgh.13907"},{"issue":"4","key":"183_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/ajg.2016.29","volume":"111","author":"S Nardelli","year":"2016","unstructured":"Nardelli S, Gioia S, Pasquale C, et al. Cognitive impairment predicts the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Am J Gastroenterol. 2016;111(4):523\u20138.","journal-title":"Am J Gastroenterol."},{"key":"183_CR30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00270-010-0016-7","volume":"34","author":"DT Cookson","year":"2011","unstructured":"Cookson DT, Zaman Z, Gordon-Smith J, et al. Management of transjugular intrahepatic portosystemic shunt (TIPS)-associated refractory hepatic encephalopathy by shunt reduction using the parallel technique: outcomes of a retrospective case series. Cardiovasc Intervent Radiol. 2011;34:92\u20139.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"183_CR31","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.2214\/AJR.09.2968","volume":"193","author":"F Fanelli","year":"2009","unstructured":"Fanelli F, Salvatori FM, Rabuffi P, et al. Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft. Am J Roentgenol. 2009;193:1696\u2013702.","journal-title":"Am J Roentgenol"},{"issue":"7","key":"183_CR32","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1053\/j.gastro.2010.02.015","volume":"138","author":"JS Bajaj","year":"2010","unstructured":"Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A, et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology. 2010;138(7):2332\u201340. \n                      https:\/\/doi.org\/10.1053\/j.gastro.2010.02.015\n                      \n                    .","journal-title":"Gastroenterology."}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-018-0183-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-018-0183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-018-0183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T19:09:57Z","timestamp":1556392197000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-018-0183-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,28]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1007\/s11938-018-0183-1","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,28]]},"assertion":[{"value":"28 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Silvia Nardelli, Lorenzo Ridola, Stefanie Gioia, and Oliviero Riggio declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}